Recovery from rabies, a universally fatal disease
© The Author(s). 2016
Received: 2 February 2016
Accepted: 29 June 2016
Published: 15 July 2016
Rabies is a zoonosis transmitted via the bites of various mammals, primarily dogs and bats. Known since antiquity, this disease may have the deadliest human fatality rates and is responsible for approximately 65,000 deaths worldwide per year.
We report the case details of a 13-year-old boy from India belonging to a South Asian ethnicity, who presented with altered sensorium one month following a dog bite. He did not receive the active rabies immunization and was managed with supportive therapy. The patient had extensive T2W (T2 weighted)/fluid attenuation and inversion recovery (FLAIR) hyper intensities involving the deep gray matter of the cerebral hemispheres, hippocampus, brainstem, and cerebellum. The diagnosis was confirmed by the demonstration of the rabies antigen from a nuchal skin biopsy and a corneal smear. The patient had a slow but significant recovery over four months and was discharged from the hospital in stable condition with severe neurological sequelae.
We report a unique case of survival after infection with a universally fatal disease.
Rabies is a zoonosis that is transmitted to humans from the bite of a rabid animal. The rabies virus is usually transmitted via dog, fox, and/or bat bites. The rabies virus is Genus Lyssa, a member of the Rhabdoviridae virus family. Rabies manifests most often as encephalitis in two clinical forms known as the furious or dumb types . The former (furious) is observed in 80 % of patients, and the dumb (paralytic) variety is observed in the remaining 20 % of patients. Rabies encephalitis has the highest case fatality rates of any infectious disease and is responsible for approximately 65,000 deaths per year worldwide. India is a major contributor to the mortality rate, accounting for more than half of all deaths .
The medical community had renewed its interest in rabies with the publication of a case of a rabies survivor who was treated with a novel protocol known as the Milwaukee protocol (MP) . Subsequent investigators who used this protocol did not find any reduction in mortality rates, and the disease still remains unconquered by modern medicine . There are only 13 reported cases of rabies survivors worldwide to date; the last case was reported in India in April, 2014 . We report another patient with this deadly disease who survived with the help of intensive critical care support.
A 13-year-old boy from India belonging to South Asian ethnicity had sustained an unprovoked bite on his right hand from a street dog on Aug. 26, 2014. He was taken to a local hospital where the wound was cleaned, and was given the first dose of intramuscular (im) Rabipur as part of the post-exposure prophylactic (PEP) treatment. He was not given rabies immunoglobulin and received two more doses of im Rabipur on days 3 and 7 after the bite. The patient complained of headache and fever from the 10th day and was treated symptomatically by the local physician. Over the next two days he started vomiting and became drowsy. He was brought to our hospital 35 days after the dog bite with an altered state of consciousness. His initial clinical examination revealed normal vital parameters with no dysautonomic features. Neurological examination showed a Glasgow Coma Scale (GCS) of 11/15 (E2 M5 V4) and intact brain stem reflexes along with signs of meningeal irritation. He had no focal neurological deficits, and a fundal examination was normal.
The possible diagnoses after neuroimaging were Japanese B-, West Nile-, or rabies-associated encephalitis. The CSF screen was negative for Herpes, Japanese B, and West Nile viruses by RT-PCR. In view of the possibility of rabies encephalitis, he was evaluated using paired serum and CSF samples for antibody titers. The paired sera showed the antibody titers in excess of 1:60,000 dilution after 45 days of vaccine treatment confirming the diagnosis of rabies infection. Subsequent to these results, other samples were collected from the nape of the neck and the cornea. The presence of the rabies antigen in the nerve twigs confirmed the diagnosis of rabies encephalitis. The confirmatory tests were conducted at the Department of Virology, Armed Forces Medical College (AFMC), Pune and the National Institute for Mental Health and Neurological Sciences (NIMHANS), Bengaluru.
He was managed in the intensive care unit (ICU) with ventilator support, barrier nursing, and strict universal precautions. The ICU course was complicated by ventilator associated pneumonia, autonomic storms, and recurrent seizures. The sympathetic storm management included the use of intravenous labetalol for tachycardia and hypertension. His management included broad spectrum antibiotics for Pseudomonas pneumonia, prophylaxis for deep vein thrombosis, a tracheostomy, antiepileptic drugs, and aggressive physiotherapy. For approximately three weeks, he remained comatose with a motor score of 3 and a GCS score of 5 with pronounced bulbar palsy. Nutritive requirements were met by the nasogastric feeds. He was weaned off of the ventilator after eight weeks of illness.
Over the next two months he developed spontaneous eye opening and was able to follow verbal commands. Motor functions partially improved with spontaneous movements of the limbs and truncal muscles. He continued with aggressive physiotherapy, and after five months of hospitalization, he was discharged in stable condition with neurological sequelae. MRI scans were conducted at serial intervals and showed the reduction of hyperintensities along with marked cortical atrophy (Fig. 1b). During the last review (two months after discharge), the patient was able to make meaningful eye contact and follow single step commands.
Rabies encephalitis is almost always a fatal disease, and therapy has mostly been palliative. Prior to 2004, there were only five documented human survivors, all of whom had received the PEP, albeit incomplete or late . In 2004, the first survivor without PEP was reported after this individual had undergone the MP. However, the use of the MP did not increase survival in subsequent cases . Our patient was managed with aggressive supportive care without the MP or steroids. Our patient survived the acute phase of rabies encephalitis and was discharged after five months of intensive nursing care in the hospital.
The reasons for patient survival after rabies infection are always conjectural depending on the number of survivors of this disease . The presence of high antibody titers in the CSF could be a strong predictor for limited neurological damage, which may help lead to survival. Unfortunately, similar data from other survivors could not be assessed; therefore, we lacked any comparative data. Another possible reason could be the intensive nursing care and proper management of the autonomic storms. Genetic variability in the host immune response to the rabies virus could also be another contributory factor to survival.
The ongoing viral effects with associated devastating brain injury were observed in serial MRI scans . However, intensive supportive care allows the immune response to clear the virus while retaining the potential for reversing the neurologic consequences. This resulted in a slow recovery despite the massive initial neurological damage. Out of the seven reported rabies survivors until 2008, only the index case that used the MP did not receive PEP. Rabies virus was detected in only one case in all of the others that were diagnosed using only the rabies antibody . Our case was diagnosed using both the rabies antibody and highly specific rabies antigen detection tests.
In conclusion, we report the case details of a young boy who survived rabies, a disease with few survivors. Our report along with other published reports, should give more impetus to researchers to unravel the mechanisms to conquer the rabies infection.
CSF, Cerebrospinal fluid; FLAIR, Fluid attenuation and inversion recovery; GCS, Glasgow coma scale; ICU, Intensive care unit; MP, Milwaukee protocol; MRI, Magnetic resonance imaging; PEP, Post exposure prophylaxis; T2W: T2 weighted
The authors sincerely acknowledge the help rendered by the Medical, Nursing and Para-Medical staff of the ICU of the Command Hospital, Lucknow for their help in the management of the case. The authors also acknowledge the help rendered by Dr SN Madhusudhana from NIMHANS, Bengaluru in the conduct of the microbiological (virology) tests of the case.
Availability of data and materials
The data pertaining to the patient has already been shared in the form of relevant clinical images. The permission has been obtained from the patient’s legal guardian for the use of the necessary images. Our manuscript pertains to only a single case report, and hence no other data set is available for testing by the reviewers.
SM was the primary care giver of the patient. AM and SJ helped SM in the management of the patient, as well as KVS. AM contributed to the initial draft of the report, SM and KVS revised the final manuscript, and all the authors have accepted the final version of this manuscript.
The authors declare that they have no competing interests.
Consent for publication
Written informed consent was obtained from the patient’s legal guardian for the publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Mitrabhakdi E, Shuangshoti S, Wannakrairot P, Lewis RA, Susuki K, Laothamatas J, et al. Difference in neuropathogenetic mechanisms in human furious and paralytic rabies. J Neurol Sci. 2005;238:3–10.View ArticlePubMedGoogle Scholar
- Sudarshan MK, Madhusudana SN, Mahendra BJ, Rao NS, Ashwath Narayana DH, Abdul Rahman S, et al. Assessing the burden ofhuman rabies in India: results of a national multi-center epidemiological survey. Int J Infect Dis. 2007;11(1):29–35.View ArticlePubMedGoogle Scholar
- Willoughby Jr RE, Tieves KS, Hoffman GM, Ghanayem NS, Amlie-Lefond CM, Schwabe MJ, et al. Survival after treatment of rabies with induction of coma. N Engl J Med. 2005;352(24):2508–14.View ArticlePubMedGoogle Scholar
- Hemachudha T, Ugolini G, Wacharapluesadee S, Sungkarat W, Shuangshoti S, Laothamatas J. Human rabies: neuropathogenesis, diagnosis, and management. Lancet Neurol. 2013;12:498–513.View ArticlePubMedGoogle Scholar
- de Souza A, Madhusudana SN. Survival from rabies encephalitis. J Neurol Sci. 2014;339:8–14.View ArticlePubMedGoogle Scholar
- Aramburo A, Willoughby RE, Bollen AW, Glaser CA, Hsieh CJ, Davis SL, et al. Failure of the Milwaukee protocol in a child with rabies. Clin Infect Dis. 2011;53:572–4.Google Scholar
- Shantavasinkul P, Tantawichien T, Wacharapluesadee S, Jeamanukoolkit A, Udomchaisakul P, Chattranukulchai P, et al. Failure of rabies postexposure prophylaxis in patients presenting with unusual manifestations. Clin Infect Dis. 2010;50:77–9.View ArticlePubMedGoogle Scholar
- Laothamatas J, Hemachudha T, Mitrabhakdi E, Wannakrairot P, Tulayadaechanont S. MR imaging in human rabies. AJNR Am J Neuroradiol. 2003;24:1102–9.Google Scholar
- Mani RS, Madhusudana SN, Mahadevan A, Reddy V, Belludi AY, Shankar SK. Utility of real-time Taqman PCR for antemortem and postmortem diagnosis of human rabies. J Med Virol. 2014;86:1804–12.Google Scholar